Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon
- PMID: 10899893
- PMCID: PMC98442
- DOI: 10.1128/IAI.68.8.4802-4804.2000
Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon
Abstract
Helicobacter pylori-induced gastritis is an essential precursor lesion for the development of peptic ulcers or gastric adenocarcinoma. We demonstrate that nonresponsiveness to H. pylori SS1 infection is dominantly inherited in mice. F(1) hybrid crosses between a nonresponder mouse and three responder strains all possessed the nonresponder phenotype. Secretion of interleukin-10 but not gamma interferon was associated with nonresponsiveness to infection.
Figures

References
-
- Aihara M, Imagawa K, Funakoshi Y, Ohmoto Y, Kikuchi M. Effects of rebamipide on production of several cytokines by human peripheral blood mononuclear cells. Dig Dis Sci. 1998;43:S160–S166. - PubMed
-
- Azuma T, Ito S, Sato F, Yamazaki Y, Miyaji H, Ito Y, Suto H, Kuriyama M, Kato T, Kohli Y. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pyloriinfection. Cancer. 1998;82:1013–1018. - PubMed
-
- Bamford K B, Fan X J, Crowe S E, Leary J F, Gourley W K, Luthra G K, Brooks E G, Graham D Y, Reyes V E, Ernst P B. Lymphocytes in the human gastric mucosa during Helicobacter pylorihave a T helper cell 1 phenotype. Gastroenterology. 1998;114:482–492. - PubMed
-
- Bell G D, Bate C M, Axon A T R, Tildesley G, Martin J L, Taylor M D, Richardson P D I. Symptomatic and endoscopic duodenal ulcer relapse rates 12 months following Helicobacter pylorieradication treatment with omeprazole and amoxycillin with or without metronidazole. Aliment Pharmacol Ther. 1996;10:637–644. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical